Non-autonomous overgrowth by oncogenic niche cells: Cellular cooperation and competition in tumorigenesis

Cancer Science

Volumn 106, Issue 12, 2015, Pages 1651-1658

  Enomoto, Masato ^a   Vaughen, John ^a   Igaki, Tatsushi ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cell competition; Cell death; Cellular cooperation; Cellular senescence; Tumor progression

Indexed keywords

DEATH ASSOCIATED INHIBITOR OF APOPTOSIS 1 PROTEIN; DECAPENTAPLEGIC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INHIBITOR OF APOPTOSIS PROTEIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; NOTCH RECEPTOR; POLYCOMB GROUP PROTEIN; PROTEIN; PROTEIN EIGER; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN YKI; RAB PROTEIN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG; WNT1 PROTEIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL GROWTH; CELL POLARITY; CELL PROLIFERATION; DROSOPHILA; ENDOCYTOSIS; GENE MUTATION; HUMAN; LIVER CELL CARCINOMA; METASTASIS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; STEM CELL NICHE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; GENETICS; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; DROSOPHILA; HUMANS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84983119804     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12816     Document Type: Article

References (89)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
2. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 2012; 12: 323-34.
3. Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
4. Snuderl M, Fazlollahi L, Le LP et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 2011; 20: 810-7.
5. Cleary AS, Leonard TL, Gestl SA, Gunther EJ. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 2014; 508: 113-7.
6. Eirew P, Steif A, Khattra J et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 2015; 518: 422-6.
7. Xu T, Rubin GM. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 1993; 117: 1223-37.
8. Pagliarini RA, Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003; 302: 1227-31.
9. Enomoto M, Igaki T. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways. J Genet Genomics 2011; 38: 461-70.
10. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010; 19: 491-505.
11. Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development 2011; 138: 9-22.
12. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501: 346-54.
13. Amoyel M, Bach EA. Cell competition: how to eliminate your neighbours. Development 2014; 141: 988-1000.
14. Levayer R, Moreno E. Mechanisms of cell competition: themes and variations. J Cell Biol 2013; 200: 689-98.
15. de Beco S, Ziosi M, Johnston LA. New frontiers in cell competition†. Dev Dyn 2012; 241: 831-41.
16. Baker NE. Cell competition. Curr Biol 2011; 21: R11-5.
17. Yeatman TJ. A renaissance for SRC. Nat Rev Cancer 2004; 4: 470-80.
18. Vidal M, Larson DE, Cagan RL. Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis. Dev Cell 2006; 10: 33-44.
19. Enomoto M, Igaki T. Src controls tumorigenesis via JNK-dependent regulation of the Hippo pathway in Drosophila. EMBO Rep 2013; 14: 65-72.
20. Mosesson Y, Mills GB, Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 2008; 8: 835-50.
21. Floyd S, De Camilli P. Endocytosis proteins and cancer: a potential link? Trends Cell Biol 1998; 8: 299-301.
22. Lanzetti L, Di Fiore PP. Endocytosis and cancer: an 'Insider' network with dangerous liaisons. Traffic 2008; 9: 2011-21.
23. Herz H-M, Chen Z, Scherr H, Lackey M, Bolduc C, Bergmann A. vps25 mosaics display non-autonomous cell survival and overgrowth, and autonomous apoptosis. Development 2006; 133: 1871-80.
24. Thompson BJ, Mathieu J, Sung H-H, Loeser E, Rørth P, Cohen SM. Tumor suppressor properties of the ESCRT-II complex component vps25 in Drosophila. Dev Cell 2005; 9: 711-20.
25. Vaccari T, Bilder D. The Drosophila tumor suppressor vps25 prevents nonautonomous overproliferation by regulating Notch trafficking. Dev Cell 2005; 9: 687-98.
26. Moberg KH, Schelble S, Burdick SK, Hariharan IK. Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell-autonomous overgrowth. Dev Cell 2005; 9: 699-710.
27. Takino K, Ohsawa S, Igaki T. Loss of Rab5 drives non-autonomous cell proliferation through TNF and Ras signaling in Drosophila. Dev Biol 2014; 395: 19-28.
28. Ballesteros-Arias L, Saavedra V, Morata G. Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila. Oncogene 2014; 33: 4377-84.
29. Soini Y, Pääkkö P, Lehto VP. Histopathological evaluation of apoptosis in cancer. Am J Pathol 1998; 153: 1041-53.
30. Haynie J, Bryant P. The effects of X-rays on the proliferation dynamics of cells in the imaginal wing disc of Drosophila melanogaster. Rouxs Arch Dev Biol 1977; 183: 85-100.
31. Sun G, Irvine KD. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol 2011; 350: 139-51.
32. Grusche FA, Degoutin JL, Richardson HE, Harvey KF. The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev Biol 2011; 350: 255-66.
33. Wu M, Pastor-Pareja JC, Xu T. Interaction between RasV12 and scribbled clones induces tumour growth and invasion. Nature 2010; 463: 545-8.
34. Herrera SC, Martín R, Morata G. Tissue homeostasis in the Wing Disc of Drosophila melanogaster: immediate response to massive damage during development. PLoS Genet 2013; 9: e1003446.
35. Igaki T, Pagliarini RA, Xu T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 2006; 16: 1139-46.
36. Srivastava A, Pastor-Pareja JC, Igaki T, Pagliarini R, Xu T. Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion. Proc Natl Acad Sci USA 2007; 104: 2721-6.
37. Huh JR, Guo M, Hay BA. Compensatory proliferation induced by cell death in the Drosophila Wing Disc requires activity of the apical cell death Caspase Dronc in a nonapoptotic role. Curr Biol 2004; 14: 1262-6.
38. Pérez-Garijo A, Martín FA, Morata G. Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila. Development 2004; 131: 5591-8.
39. Ryoo HD, Gorenc T, Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 2004; 7: 491-501.
40. Shlevkov E, Morata G. A dp53/JNK-dependant feedback amplification loop is essential for the apoptotic response to stress in Drosophila. Cell Death Differ 2012; 19: 451-60.
41. Dekanty A, Barrio L, Muzzopappa M, Auer H, Milán M. Aneuploidy-induced delaminating cells drive tumorigenesis in Drosophila epithelia. Proc Natl Acad Sci USA 2012; 109: 20549-54.
42. Pérez-Garijo A, Fuchs Y, Steller H. Apoptotic cells can induce non-autonomous apoptosis through the TNF pathway. eLife 2013; 2: e01004.
43. Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2012; 12: 23-38.
44. Igaki T, Pastor-Pareja JC, Aonuma H, Miura M, Xu T. Intrinsic tumor suppression and epithelial maintenance by endocytic activation of Eiger/TNF signaling in Drosophila. Dev Cell 2009; 16: 458-65.
45. Chen CL, Schroeder MC, Kango-Singh M, Tao C, Halder G. Tumor suppression by cell competition through regulation of the Hippo pathway. Proc Natl Acad Sci USA 2012; 109: 484-9.
46. Schroeder MC, Chen CL, Gajewski K, Halder G. A non-cell-autonomous tumor suppressor role for Stat in eliminating oncogenic scribble cells. Oncogene 2013; 32: 4471-9.
47. Brumby AM, Richardson HE. scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J 2003; 22: 5769-79.
48. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006; 25: 4647-62.
49. Ohsawa S, Sato Y, Enomoto M, Nakamura M, Betsumiya A, Igaki T. Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila. Nature 2012; 490: 547-51.
50. Nakamura M, Ohsawa S, Igaki T. Mitochondrial defects trigger proliferation of neighbouring cells via a senescence-associated secretory phenotype in Drosophila. Nat Commun 2014; 5: 5264.
51. Ohsawa S, Takemoto D, Igaki T. Dissecting tumour heterogeneity in flies: genetic basis of interclonal oncogenic cooperation. J Biochem 2014; 156: 129-36.
52. Coppé J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
53. Chabu C, Xu T. Oncogenic Ras stimulates Eiger/TNF exocytosis to promote growth. Development 2014; 141: 4729-39.
54. Moreno E. Is cell competition relevant to cancer? Nat Rev Cancer 2008; 8: 141-7.
55. Sun G, Irvine KD. Ajuba family proteins link JNK to Hippo signaling. Sci Signal 2013; 6: ra81.
56. Enomoto M, Kizawa D, Ohsawa S, Igaki T. JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity. Dev Biol 2015; 403: 162-71.
57. Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13: 246-57.
58. Lee N, Maurange C, Ringrose L, Paro R. Suppression of Polycomb group proteins by JNK signalling induces transdetermination in Drosophila imaginal discs. Nature 2005; 438: 234-7.
59. Classen A-K, Bunker BD, Harvey KF, Vaccari T, Bilder D. A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling. Nat Genet 2009; 41: 1150-5.
60. Feng S, Huang J, Wang J. Loss of the Polycomb group gene polyhomeotic induces non-autonomous cell overproliferation. EMBO Rep 2010; 12: 157-63.
61. Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res 2012; 72: 379-86.
62. Tyler DM, Li W, Zhuo N, Pellock B, Baker NE. Genes affecting cell competition in Drosophila. Genetics 2007; 175: 643-57.
63. Chen C-L, Gajewski KM, Hamaratoglu F et al. The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci USA 2010; 107: 15810-5.
64. Ling C, Zheng Y, Yin F et al. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci USA 2010; 107: 10532-7.
65. Robinson BS, Huang J, Hong Y, Moberg KH. Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein expanded. Curr Biol 2010; 20: 582-90.
66. Ribeiro P, Holder M, Frith D, Snijders AP, Tapon N. Crumbs promotes expanded recognition and degradation by the SCFSlimb/β-TrCP ubiquitin ligase. Proc Natl Acad Sci USA 2014; 111: E1980-9.
67. Bilder D, Perrimon N. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 2000; 403: 676-80.
68. Hafezi Y, Bosch JA, Hariharan IK. Differences in levels of the transmembrane protein Crumbs can influence cell survival at clonal boundaries. Dev Biol 2012; 368: 358-69.
69. Andersen DS, Colombani J, Palmerini V et al. The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth. Nature 2015; 522: 482-6.
70. Genevet A, Polesello C, Blight K et al. The Hippo pathway regulates apical-domain size independently of its growth-control function. J Cell Sci 2009; 122: 2360-70.
71. Hamaratoglu F, Gajewski K, Sansores-Garcia L, Morrison C, Tao C, Halder G. The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth. J Cell Sci 2009; 122: 2351-9.
72. Bondar T, Medzhitov R. p53-mediated hematopoietic stem and progenitor cell competition. Cell Stem Cell 2010; 6: 309-22.
73. Dejosez M, Ura H, Brandt VL, Zwaka TP. Safeguards for cell cooperation in mouse embryogenesis shown by genome-wide cheater screen. Science 2013; 341: 1511-4.
74. de la Cova C, Senoo-Matsuda N, Ziosi M et al. Supercompetitor status of Drosophila Myc cells requires p53 as a fitness sensor to reprogram metabolism and promote viability. Cell Metab 2014; 19: 470-83.
75. Gowda PS, Zhou F, Chadwell LV, McEwen DG. p53 binding prevents phosphatase-mediated inactivation of Diphosphorylated c-Jun N-terminal kinase. J Biol Chem 2012; 287: 17554-67.
76. Ruland J, Sirard C, Elia A et al. p53 Accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci USA 2001; 98: 1859-64.
77. Lee TV, Ding T, Chen Z et al. The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously. Development 2008; 135: 43-52.
78. Wells BS, Yoshida E, Johnston LA. Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity. Curr Biol 2006; 16: 1606-15.
79. Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev 2012; 26: 1268-86.
80. Yoshimoto S, Loo TM, Atarashi K et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97-101.
81. Coppé J-P, Patil CK, Rodier F et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: e301.
82. Sun Y, Campisi J, Higano C et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 2012; 18: 1359-68.
83. Maeda S, Kamata H, Luo J-L, Leffert H, Karin M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121: 977-90.
84. Sakurai T, He G, Matsuzawa A et al. Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008; 14: 156-65.
85. Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011; 17: 860-6.
86. Kurtova AV, Xiao J, Mo Q et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature 2015; 517: 209-13.
87. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011; 17: 313-9.
88. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139: 693-706.
89. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 2011; 108: 1397-402.